| Year |
Citation |
Score |
| 2020 |
Konen LM, Wright AL, Royle GA, Morris GP, Lau BK, Seow PW, Zinn R, Milham LT, Vaughan CW, Vissel B. A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability. Molecular Brain. 13: 27. PMID 32102661 DOI: 10.1186/S13041-020-0545-1 |
0.361 |
|
| 2019 |
Stayte S, Laloli KJ, Rentsch P, Lowth A, Li KM, Pickford R, Vissel B. The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain. Experimental Neurology. 113062. PMID 31513786 DOI: 10.1016/J.Expneurol.2019.113062 |
0.343 |
|
| 2019 |
Rentsch P, Stayte S, Morris GP, Vissel B. Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia. Bmc Neuroscience. 20: 5. PMID 30760214 DOI: 10.1186/S12868-019-0487-7 |
0.325 |
|
| 2018 |
Clark IA, Vissel B. Therapeutic implications of how TNF links APOE, P-tau, α-synuclein, β-amyloid, and insulin resistance in neurodegenerative diseases. British Journal of Pharmacology. PMID 30097997 DOI: 10.1111/Bph.14471 |
0.313 |
|
| 2017 |
Clark IA, Vissel B. The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Seminars in Immunopathology. PMID 28451786 DOI: 10.1007/S00281-017-0628-Y |
0.301 |
|
| 2017 |
Stayte S, Rentsch P, Tröscher AR, Bamberger M, Li KM, Vissel B. Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo. Plos One. 12: e0167211. PMID 28121982 DOI: 10.1371/Journal.Pone.0167211 |
0.358 |
|
| 2016 |
Clark IA, Vissel B. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. Journal of Neuroinflammation. 13: 236. PMID 27596607 DOI: 10.1186/S12974-016-0708-2 |
0.344 |
|
| 2015 |
Clark IA, Vissel B. A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease. Neural Plasticity. 2015: 358263. PMID 26221543 DOI: 10.1155/2015/358263 |
0.316 |
|
| 2015 |
Stayte S, Rentsch P, Li KM, Vissel B. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease. Plos One. 10: e0124325. PMID 25902062 DOI: 10.1371/Journal.Pone.0124325 |
0.327 |
|
| 2014 |
Stayte S, Vissel B. Advances in non-dopaminergic treatments for Parkinson's disease. Frontiers in Neuroscience. 8: 113. PMID 24904259 DOI: 10.3389/Fnins.2014.00113 |
0.317 |
|
| 2013 |
Clark IA, Vissel B. Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease. Biochemical Pharmacology. 86: 862-71. PMID 23939185 DOI: 10.1016/J.Bcp.2013.07.030 |
0.324 |
|
| 2013 |
Morris GP, Clark IA, Zinn R, Vissel B. Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiology of Learning and Memory. 105: 40-53. PMID 23850597 DOI: 10.1016/J.Nlm.2013.07.002 |
0.358 |
|
| 2013 |
Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, Clark IA, Abdipranoto A, Vissel B. Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. Plos One. 8: e59586. PMID 23560052 DOI: 10.1371/Journal.Pone.0059586 |
0.328 |
|
| 2012 |
Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B. Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales. Pharmacological Reviews. 64: 1004-26. PMID 22966039 DOI: 10.1124/Pr.112.005850 |
0.301 |
|
| 2012 |
Wright A, Vissel B. The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain. Frontiers in Molecular Neuroscience. 5: 34. PMID 22514516 DOI: 10.3389/Fnmol.2012.00034 |
0.331 |
|
| 2011 |
Clark IA, Alleva LM, Vissel B. TNF and leptin tell essentially the same story in alzheimer's disease Journal of Alzheimer's Disease. 26: 201-205. PMID 21593567 DOI: 10.3233/Jad-2011-110266 |
0.313 |
|
| 2011 |
McRoberts JA, Ennes HS, Marvizón JC, Fanselow MS, Mayer EA, Vissel B. Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test. Neuroscience. 172: 474-82. PMID 20974228 DOI: 10.1016/J.Neuroscience.2010.10.045 |
0.336 |
|
| 2010 |
Wiltgen BJ, Royle GA, Gray EE, Abdipranoto A, Thangthaeng N, Jacobs N, Saab F, Tonegawa S, Heinemann SF, O'Dell TJ, Fanselow MS, Vissel B. A role for calcium-permeable AMPA receptors in synaptic plasticity and learning. Plos One. 5. PMID 20927382 DOI: 10.1371/Journal.Pone.0012818 |
0.308 |
|
| 2010 |
Clark IA, Alleva LM, Vissel B. The roles of TNF in brain dysfunction and disease Pharmacology and Therapeutics. 128: 519-548. PMID 20813131 DOI: 10.1016/J.Pharmthera.2010.08.007 |
0.326 |
|
| 2010 |
Galbraith S, Daniel JA, Vissel B. A study of clustered data and approaches to its analysis Journal of Neuroscience. 30: 10601-10608. PMID 20702692 DOI: 10.1523/Jneurosci.0362-10.2010 |
0.517 |
|
| 2009 |
Daniel JA, Galbraith S, Iacovitti L, Abdipranoto A, Vissel B. Functional heterogeneity at dopamine release sites Journal of Neuroscience. 29: 14670-14680. PMID 19923300 DOI: 10.1523/Jneurosci.1349-09.2009 |
0.566 |
|
| 2009 |
Götz J, Schonrock N, Vissel B, Ittner LM. Alzheimer's disease selective vulnerability and modeling in transgenic Mice Journal of Alzheimer's Disease. 18: 243-251. PMID 19584440 DOI: 10.3233/Jad-2009-1143 |
0.343 |
|
| 2009 |
Abdipranoto-Cowley A, Jin SP, Croucher D, Daniel J, Henshall S, Galbraith S, Mervin K, Vissel B. Activin A is essential for neurogenesis following neurodegeneration Stem Cells. 27: 1330-1346. PMID 19489097 DOI: 10.1002/Stem.80 |
0.594 |
|
| 2008 |
Abdipranoto A, Wu S, Stayte S, Vissel B. The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development. Cns & Neurological Disorders Drug Targets. 7: 187-210. PMID 18537646 DOI: 10.2174/187152708784083858 |
0.365 |
|
| 2008 |
Youn DH, Royle G, Kolaj M, Vissel B, Randić M. Enhanced LTP of primary afferent neurotransmission in AMPA receptor GluR2-deficient mice. Pain. 136: 158-67. PMID 17826911 DOI: 10.1016/J.Pain.2007.07.001 |
0.329 |
|
| 2008 |
McRoberts JA, Ennes HS, Vissel B, Fanselow MS, Mayer EA. T1442 Tissue Specific Knockdown of NMDA Receptors in Primary Afferent Neurons Decreases Inflammatory Hyperalgesia Gastroenterology. 134: A-556. DOI: 10.1016/S0016-5085(08)62596-2 |
0.312 |
|
| 2007 |
Gray EE, Fink AE, Sariñana J, Vissel B, O'Dell TJ. Long-term potentiation in the hippocampal CA1 region does not require insertion and activation of GluR2-lacking AMPA receptors. Journal of Neurophysiology. 98: 2488-92. PMID 17652419 DOI: 10.1152/Jn.00473.2007 |
0.323 |
|
| 2005 |
Sonner JM, Vissel B, Royle G, Maurer A, Gong D, Baron NV, Harrison N, Fanselow M, Eger EI. The effect of three inhaled anesthetics in mice harboring mutations in the GluR6 (kainate) receptor gene. Anesthesia and Analgesia. 101: 143-8, table of cont. PMID 15976221 DOI: 10.1213/01.Ane.0000152615.53435.B4 |
0.315 |
|
| 2005 |
Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Pathobiology of dynorphins in trauma and disease. Frontiers in Bioscience : a Journal and Virtual Library. 10: 216-35. PMID 15574363 DOI: 10.2741/1522 |
0.352 |
|
| 2004 |
Petralia RS, Sans N, Wang YX, Vissel B, Chang K, Noben-Trauth K, Heinemann SF, Wenthold RJ. Loss of GLUR2 alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor subunit differentially affects remaining synaptic glutamate receptors in cerebellum and cochlear nuclei. The European Journal of Neuroscience. 19: 2017-29. PMID 15090029 DOI: 10.1111/J.0953-816X.2004.03324.X |
0.351 |
|
| 2003 |
Sans N, Vissel B, Petralia RS, Wang YX, Chang K, Royle GA, Wang CY, O'Gorman S, Heinemann SF, Wenthold RJ. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9367-73. PMID 14561864 DOI: 10.1523/Jneurosci.23-28-09367.2003 |
0.34 |
|
| 2003 |
Sekirnjak C, Vissel B, Bollinger J, Faulstich M, du Lac S. Purkinje cell synapses target physiologically unique brainstem neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6392-8. PMID 12867525 DOI: 10.1523/Jneurosci.23-15-06392.2003 |
0.313 |
|
| 2003 |
South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, et al. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5031-40. PMID 12832526 DOI: 10.1523/Jneurosci.23-12-05031.2003 |
0.302 |
|
| 2002 |
Krupp JJ, Vissel B, Thomas CG, Heinemann SF, Westbrook GL. Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors. Neuropharmacology. 42: 593-602. PMID 11985816 DOI: 10.1016/S0028-3908(02)00031-X |
0.301 |
|
| 2002 |
Luo JH, Fu ZY, Losi G, Kim BG, Prybylowski K, Vissel B, Vicini S. Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture. Neuropharmacology. 42: 306-18. PMID 11897109 DOI: 10.1016/S0028-3908(01)00188-5 |
0.332 |
|
| 2002 |
Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, Gage FH. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proceedings of the National Academy of Sciences of the United States of America. 99: 2320-5. PMID 11842206 DOI: 10.1073/Pnas.042678699 |
0.646 |
|
| 2001 |
Vissel B, Krupp JJ, Heinemann SF, Westbrook GL. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nature Neuroscience. 4: 587-96. PMID 11369939 DOI: 10.1038/88404 |
0.308 |
|
| 2001 |
Vissel B, Royle GA, Christie BR, Schiffer HH, Ghetti A, Tritto T, Perez-Otano I, Radcliffe RA, Seamans J, Sejnowski T, Wehner JM, Collins AC, O'Gorman S, Heinemann SF. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron. 29: 217-27. PMID 11182093 DOI: 10.1016/S0896-6273(01)00192-1 |
0.315 |
|
| Show low-probability matches. |